vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and Valaris Ltd (VAL). Click either name above to swap in a different company.

CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $5.2M, roughly 1.5× Valaris Ltd). Valaris Ltd runs the higher net margin — 13798.1% vs -48.7%, a 13846.7% gap on every dollar of revenue. On growth, Valaris Ltd posted the faster year-over-year revenue change (405.9% vs -2.3%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-34.1M). Over the past eight quarters, Valaris Ltd's revenue compounded faster (29.5% CAGR vs -0.1%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Valaris Limited is an offshore drilling contractor headquartered in Houston, Texas, and incorporated in Bermuda. It is the largest offshore drilling and well drilling company in the world. As of February 2025, it owned 52 rigs, including 36 offshore jackup rigs, 11 drillships, and 5 semi-submersible platform drilling rigs.

CCEL vs VAL — Head-to-Head

Bigger by revenue
CCEL
CCEL
1.5× larger
CCEL
$7.8M
$5.2M
VAL
Growing faster (revenue YoY)
VAL
VAL
+408.1% gap
VAL
405.9%
-2.3%
CCEL
Higher net margin
VAL
VAL
13846.7% more per $
VAL
13798.1%
-48.7%
CCEL
More free cash flow
CCEL
CCEL
$35.3M more FCF
CCEL
$1.2M
$-34.1M
VAL
Faster 2-yr revenue CAGR
VAL
VAL
Annualised
VAL
29.5%
-0.1%
CCEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
VAL
VAL
Revenue
$7.8M
$5.2M
Net Profit
$-3.8M
$717.5M
Gross Margin
77.9%
-7850.0%
Operating Margin
-50.6%
Net Margin
-48.7%
13798.1%
Revenue YoY
-2.3%
405.9%
Net Profit YoY
-105.1%
436.6%
EPS (diluted)
$-0.46
$10.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
VAL
VAL
Q4 25
$7.8M
$5.2M
Q3 25
$7.8M
$5.6M
Q2 25
$7.9M
$700.0K
Q1 25
$8.0M
Q4 24
$8.0M
$-1.7M
Q3 24
$8.1M
$3.9M
Q2 24
$8.0M
$4.8M
Q1 24
$7.9M
$2.6M
Net Profit
CCEL
CCEL
VAL
VAL
Q4 25
$-3.8M
$717.5M
Q3 25
$749.4K
$188.1M
Q2 25
$355.8K
$115.1M
Q1 25
$282.9K
Q4 24
$-1.9M
$133.7M
Q3 24
$1.1M
$64.6M
Q2 24
$655.8K
$149.6M
Q1 24
$556.2K
$25.5M
Gross Margin
CCEL
CCEL
VAL
VAL
Q4 25
77.9%
-7850.0%
Q3 25
77.0%
-7142.9%
Q2 25
76.6%
-56428.6%
Q1 25
75.1%
Q4 24
78.4%
24529.4%
Q3 24
73.6%
-11748.7%
Q2 24
74.8%
-9039.6%
Q1 24
73.7%
-17007.7%
Operating Margin
CCEL
CCEL
VAL
VAL
Q4 25
-50.6%
Q3 25
24.3%
Q2 25
18.8%
Q1 25
13.3%
Q4 24
-1.5%
Q3 24
17.2%
Q2 24
17.3%
Q1 24
10.5%
Net Margin
CCEL
CCEL
VAL
VAL
Q4 25
-48.7%
13798.1%
Q3 25
9.6%
3358.9%
Q2 25
4.5%
16442.9%
Q1 25
3.5%
Q4 24
-23.2%
-7864.7%
Q3 24
13.0%
1656.4%
Q2 24
8.2%
3116.7%
Q1 24
7.1%
980.8%
EPS (diluted)
CCEL
CCEL
VAL
VAL
Q4 25
$-0.46
$10.13
Q3 25
$0.09
$2.65
Q2 25
$0.04
$1.61
Q1 25
$0.03
Q4 24
$-0.23
$1.86
Q3 24
$0.13
$0.88
Q2 24
$0.08
$2.03
Q1 24
$0.07
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
VAL
VAL
Cash + ST InvestmentsLiquidity on hand
$3.3M
$599.4M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$3.2B
Total Assets
$61.7M
$5.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
VAL
VAL
Q4 25
$3.3M
$599.4M
Q3 25
$3.2M
$662.7M
Q2 25
$4.4M
$503.4M
Q1 25
$3.5M
Q4 24
$3.5M
$368.2M
Q3 24
$2.1M
$379.3M
Q2 24
$1.5M
$398.3M
Q1 24
$979.6K
$494.1M
Total Debt
CCEL
CCEL
VAL
VAL
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
VAL
VAL
Q4 25
$-18.6M
$3.2B
Q3 25
$-14.8M
$2.4B
Q2 25
$-15.6M
$2.3B
Q1 25
$-14.7M
Q4 24
$-13.2M
$2.2B
Q3 24
$-9.6M
$2.1B
Q2 24
$-10.7M
$2.2B
Q1 24
$-10.3M
$2.0B
Total Assets
CCEL
CCEL
VAL
VAL
Q4 25
$61.7M
$5.3B
Q3 25
$63.2M
$4.6B
Q2 25
$64.4M
$4.5B
Q1 25
$64.4M
Q4 24
$64.7M
$4.4B
Q3 24
$62.9M
$4.3B
Q2 24
$62.6M
$4.4B
Q1 24
$61.7M
$4.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
VAL
VAL
Operating Cash FlowLast quarter
$1.3M
$72.2M
Free Cash FlowOCF − Capex
$1.2M
$-34.1M
FCF MarginFCF / Revenue
15.5%
-655.8%
Capex IntensityCapex / Revenue
0.9%
2044.2%
Cash ConversionOCF / Net Profit
0.10×
TTM Free Cash FlowTrailing 4 quarters
$5.2M
$159.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
VAL
VAL
Q4 25
$1.3M
$72.2M
Q3 25
$2.5M
$198.1M
Q2 25
$707.0K
$120.0M
Q1 25
$954.1K
Q4 24
$2.2M
$124.6M
Q3 24
$2.4M
$193.0M
Q2 24
$1.8M
$11.5M
Q1 24
$-356.9K
$26.3M
Free Cash Flow
CCEL
CCEL
VAL
VAL
Q4 25
$1.2M
$-34.1M
Q3 25
$2.5M
$128.3M
Q2 25
$644.6K
$52.8M
Q1 25
$892.0K
Q4 24
$2.1M
$12.9M
Q3 24
$2.3M
$111.1M
Q2 24
$21.5K
$-98.7M
Q1 24
$-814.6K
$-125.0M
FCF Margin
CCEL
CCEL
VAL
VAL
Q4 25
15.5%
-655.8%
Q3 25
31.9%
2291.1%
Q2 25
8.1%
7542.9%
Q1 25
11.2%
Q4 24
26.8%
-758.8%
Q3 24
27.9%
2848.7%
Q2 24
0.3%
-2056.3%
Q1 24
-10.4%
-4807.7%
Capex Intensity
CCEL
CCEL
VAL
VAL
Q4 25
0.9%
2044.2%
Q3 25
0.5%
1246.4%
Q2 25
0.8%
9600.0%
Q1 25
0.8%
Q4 24
0.1%
-6570.6%
Q3 24
2.3%
2100.0%
Q2 24
21.8%
2295.8%
Q1 24
5.8%
5819.2%
Cash Conversion
CCEL
CCEL
VAL
VAL
Q4 25
0.10×
Q3 25
3.38×
1.05×
Q2 25
1.99×
1.04×
Q1 25
3.37×
Q4 24
0.93×
Q3 24
2.32×
2.99×
Q2 24
2.70×
0.08×
Q1 24
-0.64×
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons